ConductScience.org, home

Paper · 42941397

PG-SGA, GLIM, and CONUT in Hepatopancreatobiliary Cancer: Complementary Tools for Different Clinical Questions.

Stefanoudakis D and 9 others. J Clin Med, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. PG-SGA, GLIM, and CONUT in Hepatopancreatobiliary Cancer: Complementary Tools for Different Clinical Questions. Papers, record 42941397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42941397

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PG-SGA, GLIM, and CONUT in Hepatopancreatobiliary Cancer: Complementary Tools for Different Clinical Questions.
Journal
J Clin Med
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-28

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stefanoudakis DDimitrioshttps://orcid.org/0000-0002-2203-0644
2Frountzas MMaximoshttps://orcid.org/0000-0001-9157-9860
3Karaniki EEvahttps://orcid.org/0009-0009-2590-2389
4Vouros DDimitrioshttps://orcid.org/0000-0001-7202-0738
5Emmanouil AAthanasios
6Lidoriki IIrenehttps://orcid.org/0000-0003-4608-9621
7Kokala-Dimitropoulou VVasileia
8Theodorou DDimitrios
9Schizas DDimitrioshttps://orcid.org/0000-0002-7046-0112
10Toutouzas KGKonstantinos G

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References152

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
142,087,383Prevalence and Prognostic Impact of the Coexistence of Cachexia and Sarcopenia in Patients With Chronic Liver Diseases.J Cachexia Sarcopenia Muscle2026https://conductscience.org/library/papers/42087383PubMed
235,616,275The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma.Hepatol Commun2022https://conductscience.org/library/papers/35616275PubMed
319,887,488Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer.Clin Cancer Res2009https://conductscience.org/library/papers/19887488PubMed
42,103,402Antipyrine elimination test as a guideline for selecting patients for transhepatic biliary drainage.J Gastroenterol Hepatol1990https://conductscience.org/library/papers/2103402PubMed
539,069,476The role of cholesterol-modified prognostic nutritional index in nutritional status assessment and predicting survival after liver resection for hepatocellular carcinoma.Biosci Trends2024https://conductscience.org/library/papers/39069476PubMed
635,032,860Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.Clin Nutr2022https://conductscience.org/library/papers/35032860PubMed
742,124,055Diagnostic Performance and Agreement of MST and NUTRISCORE Compared with GLIM Criteria in Ambulatory Cancer Patients: Results from the OncoNutridos Study.Nutrients2026https://conductscience.org/library/papers/42124055PubMed
840,493,171Cachexia index as a prognostic marker in patients undergoing biliary tract cancer resection.Surg Today2025https://conductscience.org/library/papers/40493171PubMed
98,850,213Definition of standardized nutritional assessment and interventional pathways in oncology.Nutrition1996https://conductscience.org/library/papers/8850213PubMed
1041,063,283
Meta-analysis of the value of albumin-bilirubin grading on changes in liver function and its prognostic assessment in patients with hepatocellular carcinoma treated with transhepatic arterial chemoembolization.
World J Surg Oncol2025https://conductscience.org/library/papers/41063283PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42941397

GET https://conductscience.org/api/papers/v1/42941397/references?page=2